Delivery Order SPE2DB22D2211-SPE2DB25FSCBD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,074.80 to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen/ml, a pharmaceutical product used in migraine treatment. This non-competitive, firm fixed-price delivery order was issued on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,729.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors, with an ultimate completion date of July 25, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,037.40 to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pens on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. The contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen operates as a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a $3,458.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injections on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside award was competitively procured and will be performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplied the product...
- The Defense Logistics Agency awarded a $1,729.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors, with an ultimate completion date of July 23, 2025. This is a non-set-aside, competitively awarded contract for pharmaceutical supply, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,037.40 to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen delivery. This competitively awarded, firm fixed-price delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has received a delivery order from the Defense Logistics Agency (DLA) valued at $7,827.19 for Emgality 120 mg/ml pen injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 25, 2025, and represents a non-set-aside contract. The product will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,213.80 to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors, with an ultimate completion date of July 29, 2025. The contract, issued on July 28, 2025, employs firm fixed-price pricing and was awarded through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a...
- This federal contract award, valued at $2,263.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Emgality 120 mg/mL pens, a medication used to treat migraine. The contract is a firm fixed-price delivery order, with a period of performance running through March 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite...
- This delivery order for $139 against the Defense Logistics Agency's pharmaceuticals contract vehicle awards Amerisourcebergen Drug Corporation to provide 140 vials of Emgality 120 mg/ml pen injectors by October 19, 2023. To be performed in Conshohocken, Pennsylvania, this firm fixed price order utilizes the Defense Logistics Agency's indefinite delivery/indefinite quantity pharmaceuticals contract but does not include any set aside designations in the award. Amerisourcebergen will fulfill the...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCBDDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,074.80 firm fixed price delivery order for Emgality 120 mg/ml pen, a migraine treatment medication. Issued on August 1, 2025, this non-set-aside contract will be completed by August 4, 2025, with performance occurring at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military and federal healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant role in the federal medical supply chain. The company was competitively selected for this delivery order based on its established capacity to meet federal procurement requirements for pharmaceutical products and medical supplies. This transaction exemplifies the Defense Logistics Agency's ongoing pharmaceutical procurement operations supporting military healthcare programs, enabling rapid fulfillment of specific medication needs through pre-established contract vehicles that streamline the ordering and delivery process for federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/1/25 |